Navigating A 7.31% Potential Upside In The Healthcare Sector
Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates as a global pharmaceutical giant offering a diverse range of drug products. With a market capitalization of $12.42 billion, Viatris serves a broad geographic footprint that spans North America, Europe, Asia, and beyond. As the company continues to navigate the complexities of the drug manufacturing industry, investors are keenly analyzing its financial performance and growth prospects.
Currently trading at $10.65 per share, Viatris presents a potential upside of 7.31% based on the average target price of $11.43 set by analysts. The stock has experienced a 52-week range between $7.26 and $13.37, demonstrating significant volatility that could…
